Russia invaded Ukraine on 24 of February 2022. Stand with Ukraine and support us in a fight for freedom and democracy in Europe.  Stand with Ukraine!  Join us
Immunotherapy with Keytruda (Pembolizumab)
All specialties

Discover the Best Clinics and Costs for Immunotherapy with Keytruda (Pembolizumab) in Spain 2024

Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood - General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Discover the Best Clinics and Costs for Immunotherapy with Keytruda (Pembolizumab) in Spain 2024

Don't Miss Out On Top-Rated Immunotherapy with Keytruda (Pembolizumab) Specials in Spain for April 2024

Best price
Spain, Barcelona
Over 35 years of dedicated Onco-Urology expertise by Dr. Joan Carles Galceran since 1987, providing specialized Bladder cancer care. Esteemed medical practice at Centro Médico Teknon, renowned for serving celebrities and offering cutting-edge Bladder cancer treatments. Treatment following the Guidelines of Memorial Sloan Kettering Cancer Center (USA) with Keytruda (1 injection, 200 mg). Comprehensive diagnostic panel including complete blood count with cancer markers and a proteinogram. One-day hotel stay included, ensuring comfort before or after the treatment session.
Read more Hide details
4.7
Package price
$13203

22 Recent Immunotherapy with Keytruda (Pembolizumab) Reviews in Spain: Check Real Patient Experience

Mansour • Sigmoid adenocarcinoma
Pakistan
Nov 8, 2023

Verified review.
As a doctor I recommend bookimed
I introduced many patients to other medical tourism companies but most of them were not honest such as Bookinghealth.com they did fraud with our patients so finally I found an excellent company by the name of bookimed.com Iam the client Of bookimed.com since 5 years and all of my patients are satisfied from its staffs and services so as a doctor I recommend bookimed.com to choose as a right a guaranteed company in the term of your health …. Best wishes Dr.Mansoor Read more less

Алена • Online Consultation with Pediatric Oncologist
Germany
Dec 18, 2023

Verified review.
The coordinator Yulia is an excellent specialist
I would like to thank the Bookimed team for the perfectly organized consultation with the doctor. The coordinator Yulia is an excellent specialist, I felt support at all stages! Read more less

Daniel • Prostate cancer
France
Sep 9, 2022

Verified review.
The doctor was very understanding and provided excellent care
I appreciated the punctuality, efficiency and friendliness of the nursing and administrative staff. Read more less

Karen • Mammography
United States of America
May 17, 2022

Verified review.
I saw Dr
From the minute I was inquiring about an appointment through to an entire 2 hours of tests, I felt completely taken care of. Being in a foreign country where it’s not your first language can be daunting when needing healthcare. My healthcare navigator Leen was so wonderful. She brought me to each doctor or department, got me situated and was also my translator. She was kind, compassionate & so incredibly helpful. I was incredibly grateful to have her by my side. I saw Dr. Bassols who was incredibly warm, knowledgeable and put my fears at ease. The other technicians were also wonderful and caring. I highly recommend the staff and care I received at Centro Medico Teknon and the team from bookimed that connected me to them. Thank you everyone!! Read more less

Алла • Online Consultation with Oncologist
Ukraine
Jun 25, 2021

Verified review.
Impressions from the organization of consultations are only positive
We are still at the beginning of the journey, but the impressions from the organization of consultations and the doctor himself are only positive. Read more less

Georges • Prostate cancer
Belgium
Jun 8, 2021

Verified review.
The results were amazing and I'm satisfied with the treatment
Consultation was really helpful and seriously managed. Bookimed was trustworthy and quite efficient. Read more less

Elena • Sarcoma
Romania
Feb 21, 2020

Verified review.
It is difficult when we get a bad diagnosis but it's so much better when we meet kind, efficient, operative and professional doctors and assistants
It is dificult when we get a bad diagnosis but it's so much better when we meet kind, efficient, operative and profesional doctors and assistants. I had all the support I could get in the proccess of my consultation and treatment. Great team! Thank you! Read more less

Инна • Prostate cancer
Russian Federation
Feb 11, 2020

Verified review.
Dr
Many thanks to Bookimed and everyone who helped organize an urgent visit to the clinic and coordinate all the procedures. I am also very grateful for the help in booking the hotel and the support of Catherine, Daria and Ostap, human participation is incredibly important. Read more less

Евгения • Breast cancer
Russian Federation
Feb 4, 2020

Verified review.
I was amazed by the results
Satisfied with the consultation and look forward to more detailed answers. Read more less

Immunotherapy with Keytruda (Pembolizumab) Overview in Spain

Verified patient reviews - 22
Requests processed - 46119
Bookimed fees - $0

How Much Does Immunotherapy with Keytruda (Pembolizumab) Cost in Spain? Find Out Now

updated 4/25/2024
The average price of Immunotherapy with Keytruda (Pembolizumab) in Spain is $3220, the minimum price is $1073.49, and the maximum price is $5367.43.
Request the price
United States of America Turkey Mexico
Immunotherapy with Keytruda (Pembolizumab) -from $3300 -
The total cost is calculated individually. It may range depending on your medical issue, doctor's qualification, procedure complexity and related complications (if they occur). You’ll get the exact price for a plastic surgery procedure after a consultation with a doctor.
Below average
Above average
According to 3 clinics presented in the ranking
Discover the Best Immunotherapy with Keytruda (Pembolizumab) Clinics in Spain: 3 Verified Options and Prices
Check the hospital ranking based on requests and 22 reviews to pick the right Immunotherapy with Keytruda (Pembolizumab) clinic for you.
Best price
Spain, Barcelona
94% patients recommend

Read more details Hide details

Centro Medico Teknon is a modern medical center located in Barcelona, Spain. It provides a comprehensive range of medical services, with a special focus on Immunotherapy with Keytruda (Pembolizumab). Dr. Jon Karles Galseran, an Onco-Urologist with over 30 years of experience, leads the International Patient Support Center. Patients receive top-notch care, from online consultations to complex surgeries, provided by experienced and qualified doctors with the latest medical equipment and technologies. The clinic also offers guidelines of Memorial Sloan Kettering Cancer Center (USA) and Keytruda (1 injection, 200 mg).

Teknon Clinic is highly rated by patients for its friendly and helpful staff, comfortable chambers, and cleanliness. The clinic provides a relaxing atmosphere, allowing patients to focus on their recovery. Wifi and a TV are available in the ward, and transfer and accommodation services are not included.

Teknon Hospital is the No.1 choice for celebrities, sportsmen, and politicians, and provides high-quality medical care. If you are considering Immunotherapy with Keytruda (Pembolizumab) in Spain, consider Teknon Clinic, led by Dr. Jon Karles Galseran.

Immunotherapy with Keytruda (Pembolizumab) Patient Experience Reviews
Verified review.
From the minute I was inquiring about an appointment through to an entire 2 hours of tests, I felt completely taken care of. Being in a foreign country where it’s not your first language can be daunting when needing healthcare. My healthcare navigator Leen was so wonderful. She brought me to each doctor or department, got me situated and was also my translator. She was kind, compassionate & so incredibly helpful. I was incredibly grateful to have her by my side. I saw Dr. Bassols who was incredibly warm, knowledgeable and put my fears at ease. The other technicians were also wonderful and caring. I highly recommend the staff and care I received at Centro Medico Teknon and the team from bookimed that connected me to them. Thank you everyone!!
Read more
— Karen
United States of America, May 17, 2022
May 17, 2022 • Verified review.
Immunotherapy with Keytruda (Pembolizumab)
Package price
$13203
Submit a free request
Ask us any question you might have
We’ll respond in 5 minutes
Spain, Barcelona
100% patients recommend

Read more details Hide details

  • With accreditation from the European Foundation for Quality Management, the facility demonstrates a commitment to high-quality patient care.
  • Certified according to DIN EN ISO 9001 by TÜV NORD CERT, ensuring standardized excellence in healthcare services.
  • Part of Spain's largest hospital network, HM Hospitals, known for comprehensive medical and surgical care.
  • Specializes in oncology, offering personalized Immunotherapy with Keytruda (Pembolizumab) for cancer patients.
  • Equipped with the latest diagnostic tools to support effective treatment planning and monitoring for Immunotherapy patients.
Immunotherapy with Keytruda (Pembolizumab) Patient Experience Reviews
Verified review.
I really liked Dr. Kones, carefully asked everything, explained everything. Elena was also attentive and in detail translated. The consultation was held in a calm and friendly atmosphere. Thanks a lot, everyone.
Read more
— Наталья Goncharova
Russian Federation, Sep 6, 2019
Sep 6, 2019 • Verified review.
Submit a free request
Ask us any question you might have
We’ll respond in 5 minutes
Spain, Madrid
92% patients recommend

Read more details Hide details

  • With over 300 locations globally, patients have access to a wide network for Immunotherapy with Keytruda (Pembolizumab).
  • Specialized in a full range of cancer treatments, ensuring comprehensive care during Keytruda therapy.
  • Equipped with the latest technology for accurate diagnosis and treatment planning for Keytruda administration.
  • Emphasizes a patient-centered approach, providing support services for those receiving Keytruda treatments.
  • Offers seamless integration of Immunotherapy with other cancer treatments, enhancing the effectiveness of Keytruda.
Immunotherapy with Keytruda (Pembolizumab) $1073.49 - $5367.43
Submit a free request
Ask us any question you might have
We’ll respond in 5 minutes

Your Medical Travel Guide: Essential Tips and Advice

question
explanation

Get a Medical Assessment for Immunotherapy with Keytruda (Pembolizumab) in Spain: Select Your Expert from 2 Experienced Doctors

Spain, Barcelona
Francesc Bosch
Hematologist
124 years of experience
Hospital Quiron Barcelona
A specialist in lymphomas and chronic lymphocytic leukemia, he has, together with his team, achieved innovations in new technologies for the analysis of hematological diseases and new treatments for this type of disease. Professor Bosch is one of the world’s most highly reputed leaders in Chronic Lymphocytic Leukemia (CLL) and conducts both clinical and basic research on CLL and other lymphoproliferative disorders, focusing especially on the molecular pathogenesis of CLL and the development of new therapeutic approaches. Professor Bosch is currently working on more than 80 studies from phase 1 to phase 3, which means that new drugs and indications will be available in coming years thanks to research done by Professor Bosch. Education Graduated from the Faculty of Medicine of the University of Barcelona in 1988. PhD at the University of Barcelona in 1997 for his research on cyclin D1 overexpression in chronic lymphoproliferative disorders, under the supervision of Professor Elías Campo. Two-year post-doctoral fellowship in the laboratory of Professor Riccardo Dalla-Favera at the Institute of Cancer Genetics at Columbia University, New York. Investigator into Chronic Lymphocytic Leukemia (LLC) at the Hospital Clínic de Barcelona in 2000. Career President of the Spanish group for the study of chronic lymphocytic leukemia (GELLC) and he leads the clinical trials area. Involved since 1995 in the development of clinical trials on CLL, making several contributions to the evaluation of CLL prognosis and treatment. Head of Hematology at the IOB Institute of Oncology since 2004. Head of the Haematology Department and director of the Laboratory of Experimental Haematology at Barcelona’s Vall d’Hebron University Hospital since 2009. Publications Responsible for publishing more than 100 articles in prestigious scientific journals such as The New England Journal of Medicine, Nature Medicine, Cancer Cell, Blood, Journal of Clinical Oncology, and Leukemia. Author and co-author of several reviews and book chapters on CLL and other lymphoproliferative disorders. Teaching Professor of Haematology at the Vall d’Hebron University Hospital of Barcelona.
Spain, Madrid
Lopez Ibor
Pediatric hematologist/oncologist
30 years of experience
Hospital HM Monteprincipe
The prestigious Dr. López-Ibor has a degree in Medicine from the Complutense University of Madrid and a doctorate from the University of Barcelona. Specialist in Pediatric Hematology and Oncology from the University of Maryland (United States), she is an expert in the treatment of bone and brain tumors, as well as in leukemia and hematological diseases. With more than two decades of experience, he currently directs the Pediatric Hematology and Oncology Unit of the HM Montepríncipe Hospital, where children and adolescents are cared for. Previously, he held the same position at the Hospital Universitario Clínica San Rafael. In addition, she is the author of numerous national and international scientific publications.

FAQ about Immunotherapy with Keytruda (Pembolizumab) in Spain

What is Keytruda (Pembrolizumab)?

Pembrolizumab belongs to the group of the immunotherapy drugs — type of medicine that can treat certain cancers by influencing on patient's immune system. It blocks a protective mechanism of cancer cells and allows the immune system to destroy them. Monoclonal antibody to programmed cell death-1 protein (PD-1) blocks the interaction between PD-1 and its ligands — PD-L1 and PD-L2.

Keytruda prices are specified in this listing. Submit a request to get a personalized quote.

Is Pembrolizumab FDA approved?

On May 23, 2017, the U.S. Food and Drug Administration granted for Pembrolizumab (Keytruda) an accelerated approval — faster approval of drugs for serious conditions that fill an unmet medical need. FDA allowed prescribing immunotherapy new drug to treat patients whose cancers have a specific genetic feature (biomarker).

What are Keytruda success rates?

During the clinical trials of Keytruda, the following indicators were achieved:

Period

The survival rate of patients with 3-4 stages of cancer

6 month

92%

1 year

69%

1,5 years

62%

2 years

58%

Who produces Keytruda?

The manufacturer is Merck & Co., Inc. — an American pharmaceutical company and one of the largest pharmaceutical companies in the world. Research performed at Merck has led to FDA approval of 63 new drugs. Company has developed more new drugs than any other company in the USA.

This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

Bookimed editorial policy

Bookimed, a leading global medical tourism platform, is committed to helping clients looking for Immunotherapy with Keytruda (Pembolizumab) by offering expert assistance and trustworthy medical solutions for every situation. Smart automatic ranking system is used to compose transparent clinic listings, meticulously maintained by a data scientist using AI for accuracy. The platform guarantees authenticity by publishing reviews from real patients after their treatments. Bookimed offers comprehensive medical solutions, with updates from clinics to ensure trustworthiness. The content about Immunotherapy with Keytruda (Pembolizumab), crafted by experienced medical authors and reviewed by specialists, adheres to Bookimed"s Editorial Guidelines, reflecting the platform"s commitment to delivering high-quality and clear health information. For more details or inquiries, feel free to contact us at marketing@bookimed.com or learn more about us and our mission here.

Immunotherapy with Keytruda (Pembolizumab) Bookimed Medical Advisory Board expert

Doctor Yesim Yildirim is an oncologist certified by the European Society of Medical Oncology (ESMO). Affiliated with numerous hospitals in the United States and Turkey, including the University of Maryland Medical Center, Johns Hopkins Hospital and Memorial Sisli Hospital. She has over 20 years of experience and has a special interest in preventive medicine, diabetes, and hypertension. Holds an MBA in Healthcare Management and shares her expertise with Bookimed from 2022.

The Medical Advisory Board expert is a verified credible medical professional with solid theoretical background and practical experience in the field. The expert provides support related to medical content accuracy for medical writers and performs educational workshops to Bookimed coordinators serving patient requests.

The medical content creation under the expert’s control follows rigorous and well-established procedure to be informative, trustworthy, and transparent and making Bookimed.com a credible source of evidence-based health information.